Fat Loss & Metabolic Health

How Long Does Tirzepatide Take to Work? The Week-by-Week Timeline

Quick answerThree clocks run at once, and they answer three different questions. In the blood: peak plasma concentration a median 24 hours…

Tirzepatide With B12: Benefits, Risks and the 2026 Impurity Finding

Quick answerThe combination only exists in compounded vials, and the case for it has weakened, not strengthened. Approved tirzepatide contains no B12.…

Tirzepatide and Alcohol: Is It Safe to Drink, and What the Risks Are

Quick answerNothing in the label forbids it, and nothing in the label clears it either. Alcohol is not listed as a contraindication…

Mounjaro and Zepbound Injection Sites: Where to Inject, and Why Rotate

Quick answerThree sites, all equivalent for absorption, rotated every week. Where: the abdomen, the thigh, or the back of the upper arm.…

5-Amino-1MQ: Results, Side Effects and What the Research Actually Shows

Quick answerShort version: the fat-loss story is real in rodents and untested in people. It is not a peptide. It is a…

Cagrilintide Side Effects: What the Trial Data Actually Show

In randomised human trials, the dominant documented adverse events with cagrilintide are gastrointestinal and closely tied to dose escalation. In the largest…

MOTS-c Side Effects: What the Research Actually Documents

There is no published human safety dataset for exogenously administered MOTS-c. No completed clinical trial has reported adverse events, the FDA Adverse…

GLP-1 and Hair Loss: What the Trial Data Actually Show

The short answer is yes: GLP-1 hair loss is real, it is measurable, and it was in the FDA-approved labeling from the…

Mazdutide vs Tirzepatide: What the Evidence Actually Compares

The short answer: mazdutide and tirzepatide are both once-weekly, single-molecule dual receptor agonists, but they hit different second receptors — mazdutide (IBI362…

5-Amino-1MQ Oral vs Injectable: Bioavailability, Half-Life & What Research Shows

No half-life has ever been published for 5-Amino-1MQ — in any species, by any route — and no study has compared its…